NuCana (NCNA) Share-based Compensation (2017 - 2025)

NuCana's (NCNA) quarterly Share-based Compensation came in at $1.2 million in Q4 2025, up 4467.5% year-on-year from $25773.3 in Q4 2024, and down 2.63% quarter-over-quarter from $1.2 million in Q3 2025.

NuCana (NCNA) Share-based Compensation (2017 - 2025) Analysis & Trends

NuCana has disclosed Share-based Compensation across 9 years of filings, most recently posting $1.2 million for Q4 2025.

  • Share-based Compensation for Q4 2025 came in at $1.2 million, up 4467.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.8 million (up 35.87% YoY), and the FY2025 annual result was $13.2 million, up 528.41% from the prior year.
  • Share-based Compensation came in at $1.2 million for Q4 2025 at NuCana, down from $1.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.5 million in Q2 2021 to a low of -$26953.5 in Q4 2024.
  • The 5-year median for Share-based Compensation is $1.3 million (2025), against an average of $1.4 million.
  • Across the five-year window, Share-based Compensation plunged 102.77% in 2024 and jumped 4467.5% in 2025, its largest moves.
  • NuCana's Share-based Compensation stood at $2.4 million in 2021, then slumped by 37.58% to $1.5 million in 2022, then tumbled by 33.73% to $973063.1 in 2023, then slumped by 102.77% to -$26953.5 in 2024, then surged by 4467.5% to $1.2 million in 2025.
  • The last three Share-based Compensation figures came in at $1.2 million (Q4 2025), $1.2 million (Q3 2025), and -$26953.5 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 305,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 166.40 Mn
9 Abivax 94.26 Bn 94.26 Bn - 26.47 Mn
10 NuCana 29.13 Bn 29.13 Bn - 1.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.18 Mn
Dec 31, 2025 1.18 Mn
Sep 30, 2025 1.21 Mn
Sep 30, 2025 1.21 Mn
Dec 31, 2024 -26,953.54
Dec 31, 2024 -26,953.54
Sep 30, 2024 487,237.56
Sep 30, 2024 487,237.56
Jun 30, 2024 840,639.02
Jun 30, 2024 840,639.02
Mar 31, 2024 794,092.38
Mar 31, 2024 794,092.38
Dec 31, 2023 973,063.08
Dec 31, 2023 973,063.08
Sep 30, 2023 1.11 Mn
Sep 30, 2023 1.11 Mn
Jun 30, 2023 1.32 Mn
Jun 30, 2023 1.32 Mn
Mar 31, 2023 1.39 Mn
Mar 31, 2023 1.39 Mn